Garbriel Afram (Gabriel Afram)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Prognostic Factors

Top Venues

European journal of haematology

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Roza Chaireti, Katarina Uttervall, Vincent Luong, Johan Lund, Muhammad Kashif, Gösta Gahrton, Evren Alici, Hareth Nahi, Garbriel Afram
Response to Caravita di Toritto and Rago. European journal of haematology (2022)
Garbriel Afram, Roza Chaireti, Katarina Uttervall, Vincent Luong, Johan Lund, Muhammad Kashif, Gösta Gahrton, Evren Alici, Hareth Nahi
Conditioning with melphalan 200 mg/m 2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care. European journal of haematology 109 (6) (2022)
Garbriel Afram, Katharina Helene Susek, Katarina Uttervall, Johanna Dehlsen Wersäll, Arnika Kathleen Wagner, Vincent Luong, Johan Lund, Gösta Gahrton, Evren Alici, Hareth Nahi
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups. European journal of haematology 106 (4) (2021)
Garbriel Afram, Charlotte Gran, Johanna B Bruchfeld, Arnika Kathleen Wagner, Alamdar Hussain, Evren Alici, Hareth Nahi
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment. European journal of haematology 105 (2) (2020)
Garbriel Afram, Jose Antonio Pérez Simón, Mats Remberger, Teresa Caballero-Velázquez, Rodrigo Martino, Jose Luis Piñana, Olle Ringden, Albert Esquirol, Lucia Lopez-Corral, Irene Garcia, Oriana López-Godino, Jordi Sierra, Dolores Caballero, Per Ljungman, Lourdes Vazquez, Hans Hägglund
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting. Medical oncology (Northwood, London, England) 35 (6) (2018)